Close

MKM Partners Raises Numbers on Eli Lilly (LLY); Getting More Constructive

July 26, 2012 11:05 AM EDT
Get Alerts LLY Hot Sheet
Price: $777.96 -0.03%

Rating Summary:
    24 Buy, 8 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
MKM Partners reiterates a 'Neutral' on Eli Lilly (NYSE: LLY) price target of $44.00 (from $40.00).

Analyst, Jon LeCroy, said, "Based on the 2Q12 performance, we are increasing our 2012E-2016E revenue, which also increases our 2012E-2016E EPS. Our new 2012-2016 EPS estimates are $3.43, $3.90, $2.75, $3.09 and $3.57 from $3.22, $3.73, $2.63, $2.85 and $3.12, respectively. Higher EPS estimates lead us to increase our fair value estimate. We reiterate our rating and could get more constructive on Lilly shares once the Alzheimer’s data for solanezumab (we assume a negative outcome) are released in October, all else being equal."

For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.

Shares of Eli Lilly closed at $43.12 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change